Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos for FOP.

Asahi Kasei has signed a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures for approximately ...

The organised crime group were selling unlicensed weight loss-substances online, using social media to market products.

Novo Nordisk and Vivtex are to co-develop next-generation oral biologic therapies to treat obesity, diabetes and related ...

AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

Children are protected against fewer diseases as per the new schedule, which the states say will damage public health.

Boehringer in terms of licensing deals, with a majority of these agreements being oncology or immunology-focused.

The European Commission (EC) has approved a higher dose of Novo Nordisk’s Wegovy (semaglutide), marking a win for the ...

This deal adds two more siRNA candidates to GSK’s pipeline, which is expanding as the company looks to offset the impact of ...

J&J has received the US FDA approval for a new monthly dosing schedule for the combination therapy Rybrevant Faspro to treat ...

J&J's Pennsylvania cell therapy manufacturing site is one of four US-based facilities the company plans to build over the ...

Boehringer Ingelheim India has signed a Memorandum of Understanding (MoU) to enhance pharmaceutical education and research ...